Sakurai Y - Search Results

1

The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus.

Sato S, Li K, Kameyama T, Hayashi T, Ishida Y, Murakami S, Watanabe T, Iijima S, Sakurai Y, Watashi K, Tsutsumi S, Sato Y, Akita H, Wakita T, Rice CM, Harashima H, Kohara M, Tanaka Y, Takaoka A. Sato S, et al. Among authors: sakurai y. Immunity. 2015 Jan 20;42(1):123-32. doi: 10.1016/j.immuni.2014.12.016. Epub 2014 Dec 18. Immunity. 2015. PMID: 25557055 Free article.

2

Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.

Sakurai Y, Hatakeyama H, Akita H, Oishi M, Nagasaki Y, Futaki S, Harashima H. Sakurai Y, et al. Biol Pharm Bull. 2009 May;32(5):928-32. doi: 10.1248/bpb.32.928. Biol Pharm Bull. 2009. PMID: 19420766 Free article.

3

Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA.

Sakurai Y, Hatakeyama H, Sato Y, Akita H, Takayama K, Kobayashi S, Futaki S, Harashima H. Sakurai Y, et al. Biomaterials. 2011 Aug;32(24):5733-42. doi: 10.1016/j.biomaterials.2011.04.047. Epub 2011 May 24. Biomaterials. 2011. PMID: 21605898 Free article.

4

A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.

Sato Y, Hatakeyama H, Sakurai Y, Hyodo M, Akita H, Harashima H. Sato Y, et al. Among authors: sakurai y. J Control Release. 2012 Nov 10;163(3):267-76. doi: 10.1016/j.jconrel.2012.09.009. Epub 2012 Sep 20. J Control Release. 2012. PMID: 23000694 Free article.

5

Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system.

Sakurai Y, Hatakeyama H, Sato Y, Hyodo M, Akita H, Harashima H. Sakurai Y, et al. Mol Ther. 2013 Jun;21(6):1195-203. doi: 10.1038/mt.2013.57. Epub 2013 Apr 9. Mol Ther. 2013. PMID: 23568259 Free PMC article.

6

A liposomal delivery system that targets liver endothelial cells based on a new peptide motif present in the ApoB-100 sequence.

Akhter A, Hayashi Y, Sakurai Y, Ohga N, Hida K, Harashima H. Akhter A, et al. Among authors: sakurai y. Int J Pharm. 2013 Nov 1;456(1):195-201. doi: 10.1016/j.ijpharm.2013.07.068. Epub 2013 Aug 7. Int J Pharm. 2013. PMID: 23933440 Free article.

7

RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.

Sakurai Y, Hatakeyama H, Sato Y, Hyodo M, Akita H, Ohga N, Hida K, Harashima H. Sakurai Y, et al. J Control Release. 2014 Jan 10;173:110-8. doi: 10.1016/j.jconrel.2013.10.003. Epub 2013 Oct 11. J Control Release. 2014. PMID: 24120854 Free article.

8

Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes.

Hayashi Y, Suemitsu E, Kajimoto K, Sato Y, Akhter A, Sakurai Y, Hatakeyama H, Hyodo M, Kaji N, Baba Y, Harashima H. Hayashi Y, et al. Among authors: sakurai y. Mol Ther Nucleic Acids. 2014 Mar 18;3(3):e154. doi: 10.1038/mtna.2014.4. Mol Ther Nucleic Acids. 2014. PMID: 24643205 Free PMC article.

9

"Programmed packaging" for gene delivery.

Hyodo M, Sakurai Y, Akita H, Harashima H. Hyodo M, et al. Among authors: sakurai y. J Control Release. 2014 Nov 10;193:316-23. doi: 10.1016/j.jconrel.2014.04.023. Epub 2014 Apr 26. J Control Release. 2014. PMID: 24780263 Free article. Review.

10

Improvement of doxorubicin efficacy using liposomal anti-polo-like kinase 1 siRNA in human renal cell carcinomas.

Sakurai Y, Hatakeyama H, Akita H, Harashima H. Sakurai Y, et al. Mol Pharm. 2014 Aug 4;11(8):2713-9. doi: 10.1021/mp500245z. Epub 2014 May 12. Mol Pharm. 2014. PMID: 24800640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,342 results

Search Page

Filters